news

Groundbreaking News about Telomerase Activation!
UCLA on Nov.10 announced groundbreaking pre-clinical data on TAT2, a small molecule telomerase activator.

This study was conducted by Professor Rita B. Effros at UCLA and collaborating scientists from the Geron Corporation. It will be printed in The Journal of Immunology on November 15 2008. Past research concludes that individuals with high white blood cell telomerase activity have enhanced immune function. TAT2 was shown in this study to increase telomerase and similarly strengthen the immune system. This peer reviewed paper demonstrates the potential of products that can activate telomerase.

As the licensee of Geron's anti-aging technology for activating telomerase, T.A. Sciences congratulates Geron and Professor Effros on this exciting new scientific research.

For further information click on the following links:
http://www.geron.com/media/pressview.aspx?id=857

http://www.newsroom.ucla.edu/portal/ucla/researchers-use-chemical-from-71498.aspx

www.jimmunol.org/cgi/content/full/181/10/7400


Noel Thomas Patton
Telomerase Activation Sciences, Inc.